title: Towards a hit for every target.
abstract: Technological advances coupled with novel collaborative strategies for compound sourcing and management are poised to transform the utility of high-throughput screening.
authors.affiliation: AstraZeneca, Cambridge Science Park, 310 Milton Road, Cambridge CB4 0FZ, UK.
authors.forename: Steve
authors.initials: S
authors.lastname: Rees
authors.affiliation: Fraunhofer Institute for Molecular Biology and Applied Ecology Ecology IME ScreeningPort, Schnackenburgallee 114, 22525 Hamburg, Germany.
authors.forename: Philip
authors.initials: P
authors.lastname: Gribbon
authors.affiliation: AstraZeneca, 2 Kingdom Street, London W2 6BD, UK.
authors.forename: Karen
authors.initials: K
authors.lastname: Birmingham
authors.affiliation: Lead Discovery, Epizyme, 400 Technology Square, Cambridge, Massachusetts 02139, USA.
authors.forename: William P
authors.initials: WP
authors.lastname: Janzen
authors.affiliation: AstraZeneca, Cambridge Science Park, 310 Milton Road, Cambridge CB4 0FZ, UK.
authors.forename: Garry
authors.initials: G
authors.lastname: Pairaudeau
mesh_terms: D055808:Drug Discovery / Q000379:methods*; D004345:Drug Industry / Q000379:methods; D057166:High-Throughput Screening Assays / Q000379:methods*; D055818:Public-Private Sector Partnerships